Clinical Trial Detail

NCT ID NCT03712358
Title PVSRIPO for Patients With Unresectable Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Istari Oncology, Inc.
Indications

melanoma

Therapies

PVSRIPO

Age Groups: adult senior

No variant requirements are available.